MDRNA Expands Bladder Cancer Collaboration with Vancouver Prostate Centre

Earlier this year, MDRNA announced that it had added bladder cancer to its formal pipeline after its collaboration with VPC had yielded positive results in a rodent model of bladder cancer.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.